Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
62.70
+1.80 (2.96%)
At close: Feb 26, 2026
21.75%
Market Cap 6.73B
Revenue (ttm) 9.52B
Net Income (ttm) 537.75M
Shares Out 107.42M
EPS (ttm) 4.99
PE Ratio 12.58
Forward PE n/a
Dividend 1.40 (2.23%)
Ex-Dividend Date Nov 20, 2025
Volume 599,360
Average Volume 886,844
Open 61.20
Previous Close 60.90
Day's Range 61.20 - 62.90
52-Week Range 45.50 - 65.80
Beta -0.08
RSI 63.29
Earnings Date Jan 28, 2026

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,798
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In fiscal year 2025, Navana Pharmaceuticals's revenue was 8.84 billion, an increase of 28.19% compared to the previous year's 6.90 billion. Earnings were 487.81 million, an increase of 20.56%.

Financial Statements

News

There is no news available yet.